{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-205553","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2025-09-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.101166+00:00","generated_at":"2026-05-17T06:23:10.771321+00:00","sec_items":["3.03","8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vor Biopharma announces 1-for-20 reverse stock split effective Sept 18, 2025","bullets":["Reverse stock split at 1-for-20 ratio effective 5:00 p.m. ET on September 18, 2025.","Pre-split shares ~136.8M; post-split ~6.84M (subject to fractional share cash-out).","Split-adjusted trading on Nasdaq begins September 19, 2025; new CUSIP 929033207.","Proportionate adjustments to exercise prices and shares under equity plans and warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-205553","json":"https://secwatch.observer/filing/0001193125-25-205553.json","markdown":"https://secwatch.observer/filing/0001193125-25-205553.md","text":"https://secwatch.observer/filing/0001193125-25-205553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525205553/0001193125-25-205553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312525205553/d945826d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:23:10.771321+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}